Data from Transcriptome-Wide Association Study Identifies New Candidate Susceptibility Genes for Glioma

<div>Abstract<p>Genome-wide association studies (GWAS) have so far identified 25 loci associated with glioma risk, with most showing specificity for either glioblastoma (GBM) or non-GBM tumors. The majority of these GWAS susceptibility variants reside in noncoding regions and the causal genes underlying the associations are largely unknown. Here we performed a transcriptome-wide association study to search for novel risk loci and candidate causal genes at known GWAS loci using Genotype-Tissue Expression Project (GTEx) data to predict <i>cis</i>-predicted gene expression in relation to GBM and non-GBM risk in conjunction with GWAS summary statistics on 12,488 glioma cases (6,183 GBM and 5,820 non-GBM) and 18,169 controls. Imposing a Bonferroni-corrected significance level of <i>P</i> < 5.69 × 10⁻⁶, we identified 31 genes, including <i>GALNT6</i> at 12q13.33, as a candidate novel risk locus for GBM (mean <i>Z</i> = 4.43; <i>P</i> = 5.68 × 10⁻⁶). <i>GALNT6</i> resides at least 55 Mb away from any previously identified glioma risk variant, while all other 30 significantly associated genes were located within 1 Mb of known GWAS-identified loci and were not significant after conditioning on the known GWAS-identified variants. These data identify a novel locus (<i>GALNT6</i> at 12q13.33) and 30 genes at 12 known glioma risk loci associated with glioma risk, providing further insights into glioma tumorigenesis.</p>Significance:<p>This study identifies new genes associated with glioma risk, increasing understanding of how these tumors develop.</p></div>

Duke Scholars

Author Quinn Ostrom Neurosurgery, Neuro-Oncology